Publikationen

Die Publikationen von Prof. Thaçi können Sie auf PubMed.gov finden.

Im folgenden finden Sie eine Liste mit ausgewählten Publikationen aus den Jahren 2020 - 2022:

Twice-weekly topical calcipotriene/betamethasone dipropionate foam as proactive management of plaque psoriasis increases time in remission and is well tolerated over 52 weeks (PSO-LONG trial).

Mark Lebwohl, Leon Kircik, Jean-Philippe Lacour, Monika Liljedahl, Charles Lynde, Marie Holst Mørch, Kim A Papp, Jean-Luc Perrot, Linda Stein Gold, Amrit Takhar, Diamant Thaçi, Richard B Warren, Andreas Wollenberg.

veröffentlicht im Journal of the American Academy of Dermatology im September 2020.

 

Laboratory Safety of Dupilumab in Patients Aged 6-11 Years with Severe Atopic Dermatitis: Results from a Phase III Clinical Trial.

Amy S Paller, Andreas Wollenberg, Elaine Siegfried, Diamant Thaçi, Michael J Cork, Peter D Arkwright, Melinda Gooderham, Xian Sun, John T O'Malley, Faisal A Khokhar, Jignesh Vakil, Ashish Bansal, Karli Rosner, Brad Shumel, Noah A Levit

veröffentlicht im Pediatric Drugs im August 2021.

 

Deucravacitinib versus placebo and apremilast in moderate to severe plaque psoriasis: efficacy and safety results from the 52-week, randomized, double-blinded, placebo-controlled phase 3 POETYK PSO-1 trial.

April W Armstrong, Melinda Gooderham, Richard B Warren, Kim A Papp, Bruce Strober, Diamant Thaçi, Akimichi Morita, Jacek C Szepietowski, Shinichi Imafuku, Elizabeth Colston, John Throup, Sudeep Kundu, Steve Schoenfeld, Misti Linaberry, Subhashis Banerjee, Andrew Blauvelt.

veröffentlicht im Journal of the American Academy of Dermatology im Juli 2022.

 

Efficacy of guselkumab versus secukinumab in subpopulations of patients with moderate-to-severe plaque psoriasis: results from the ECLIPSE study.

Andrew Blauvelt, April W Armstrong, Richard G Langley, Kurt Gebauer, Diamant Thaçi, Jerry Bagel, Lyn C Guenther, Carle Paul, Bruce Randazzo, Susan Flavin, Ming-Chun Hsu, Yin You, Kristian Reich.

veröffentlicht im Journal of Dermatological Treatment im August 2021.

 

Direct comparison of risankizumab and fumaric acid esters in systemic therapy-naïve patients with moderate-to-severe plaque psoriasis: a randomized controlled trial.

D Thaçi, K Eyerich, A Pinter, M Sebastian, K Unnebrink, S Rubant, D A Williams, P Weisenseel.

veröffentlicht im British Journal of Dermatology im Januar 2022.

 

Case report: Clinical features of COVID-19 vaccine-induced exacerbation of psoriasis-A case series and mini review.

Sascha Ständer, Henner Zirpel, Florin Bujoreanu, Alin Laurentiu Tatu, Ralf J Ludwig, Diamant Thaçi

veröffentlicht im Frontiers in Medicine im September 2022.

 

Abrocitinib versus Placebo or Dupilumab for Atopic Dermatitis.

Thomas Bieber, Eric L Simpson, Jonathan I Silverberg, Diamant Thaçi, Carle Paul, Andrew E Pink, Yoko Kataoka, Chia-Yu Chu, Marco DiBonaventura, Ricardo Rojo, Jeremias Antinew, Ileana Ionita, Rodney Sinclair, Seth Forman, Jacek Zdybski, Pinaki Biswas, Bimal Malhotra, Fan Zhang, Hernan Valdez, JADE COMPARE Investigators

veröffentlicht im The New England Journal of Medicine im März 2021.

 

Once-daily upadacitinib versus placebo in adolescents and adults with moderate-to-severe atopic dermatitis (Measure Up 1 and Measure Up 2): results from two replicate double-blind, randomised controlled phase 3 trials.

Emma Guttman-Yassky, Henrique D Teixeira, Eric L Simpson, Kim A Papp, Aileen L Pangan, Andrew Blauvelt, Diamant Thaçi, Chia-Yu Chu, H Chih-Ho Hong, Norito Katoh, Amy S Paller, Brian Calimlim, Yihua Gu, Xiaofei Hu, Meng Liu, Yang Yang, John Liu, Allan R Tenorio, Alvina D Chu, Alan D Irvine.

veröffentlicht im The Lancet im Mai 2021.